Does TERAZOSIN Cause Lung opacity? 16 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Lung opacity have been filed in association with TERAZOSIN (terazosin). This represents 3.0% of all adverse event reports for TERAZOSIN.
16
Reports of Lung opacity with TERAZOSIN
3.0%
of all TERAZOSIN reports
0
Deaths
16
Hospitalizations
How Dangerous Is Lung opacity From TERAZOSIN?
Of the 16 reports, 16 (100.0%) required hospitalization, and 11 (68.8%) were considered life-threatening.
Is Lung opacity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TERAZOSIN. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does TERAZOSIN Cause?
Therapeutic product effect incomplete (75)
Asthma (66)
Dyspnoea (60)
Drug ineffective (56)
Dizziness (47)
Cough (46)
Chest pain (42)
Malaise (40)
Hospitalisation (37)
Drug hypersensitivity (36)
What Other Drugs Cause Lung opacity?
ALBUTEROL (296)
PREDNISONE (216)
TIOTROPIUM (196)
LANSOPRAZOLE (166)
IPRATROPIUM (157)
ACETAMINOPHEN (153)
MEPOLIZUMAB (149)
PANTOPRAZOLE (140)
BUDESONIDE\FORMOTEROL (139)
MONTELUKAST (137)
Which TERAZOSIN Alternatives Have Lower Lung opacity Risk?
TERAZOSIN vs TERAZOSIN\TERAZOSIN
TERAZOSIN vs TERBINAFINE
TERAZOSIN vs TERBINAFINE\TERBINAFINE
TERAZOSIN vs TERBUTALINE
TERAZOSIN vs TERCONAZOLE